Paris – Eurobonds ended a solid week on Friday with small reductions. Downgraded by the continued recovery of the euro, EuroStoxx closed 50 weeks at 0.12 percent to 3565.52 points. However, he completed trading week about 0.4 percent higher – the seventh week plus in a row.
The euro started Friday on the profits last day and again traded well above $ 1.19. Conversely, the market talked about earnings in the US currency. For companies from the euro area, the recovery in the single currency is a disadvantage, because in contrast to earlier days, the outlook for local businesses is decreasing again.
In Paris, Cac 40 was only 0.07 percent to 5541.94 points after. In Italy, however, the last, difficult political uncertainty no longer came: the leading index FTSE MIB rose 0.52 percent in Milan. Outside the euro area, the British FTSE 1
Good news came in Italy from Monte dei Paschi di Siena : The crisis bank had been in black during the first quarter and dampened its share price by 17.7 percent.
By far the best sector in the Stoxx 600 sector overview was raw material stocks of just under 1.8 percent. Here came the latest business figures of ArcelorMittal well. Rising demand and higher prices had increased sales and profit in the world's largest steel manufacturer at the beginning of the year – and pushed up its paper by more than 2 percent.
The mining company's share of mining increased by 3.8 percent in London] Randgold Resources – According to traders, bargain owners were at work after disappointment the day before due to disappointing figures.
Among the other individual stocks Saint-Gobain shares the EuroStoxx peak by 2.65 percent. The French building materials manufacturer had settled the annual dispute over the takeover of the Swiss manufacturer of building chemicals Sika by now refraining from the control flow. Sika Sika participation certificate shot up in Zurich by about 8 percent.
At the same time, the paper of Roche in Zurich lost 1.7 percent. The pharmaceutical company had previously reported a failure of the drug Tecentriq in the treatment of colon cancer.
Finally, in London, a buy-out bid of the shares in ZPG ended by more than 30 percent. This was about the premium that the financial investor Silver Lake is willing to pay for the real estate platform. Market analyst David Madden from CMC Markets spoke of a great prize. (AWP / mc / pg)  EUR Next
The stock market price of Google Finance